Paper26528362
Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran.
Ansarin K and 20 others. Tanaffos, 2015. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran. Papers, record 26528362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26528362
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References182
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19483109 | T-helper type 2-driven inflammation defines major subphenotypes of asthma. | Am J Respir Crit Care Med | 2009 | https://conductscience.org/library/papers/19483109 | PubMed |
| 2 | 11867826 | Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. | Thorax | 2002 | https://conductscience.org/library/papers/11867826 | PubMed |
| 3 | 20031382 | Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study. | Respir Med | 2010 | https://conductscience.org/library/papers/20031382 | PubMed |
| 4 | 9563738 | Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. | Am J Respir Crit Care Med | 1998 | https://conductscience.org/library/papers/9563738 | PubMed |
| 5 | 22513916 | Anticholinergic therapy for acute asthma in children. | Cochrane Database Syst Rev | 2012 | https://conductscience.org/library/papers/22513916 | PubMed |
| 6 | 10392993 | Non-eosinophilic corticosteroid unresponsive asthma. | Lancet | 1999 | https://conductscience.org/library/papers/10392993 | PubMed |
| 7 | 20603348 | AGREE II: advancing guideline development, reporting and evaluation in health care. | CMAJ | 2010 | https://conductscience.org/library/papers/20603348 | PubMed |
| 8 | 16341266 | Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. | J Clin Invest | 2006 | https://conductscience.org/library/papers/16341266 | PubMed |
| 9 | 22551116 | Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients. | J Asthma | 2012 | https://conductscience.org/library/papers/22551116 | PubMed |
| 10 | 24780091 | Real life study of three years omalizumab in patients with difficult-to-control asthma. | Allergol Immunopathol (Madr) | 2015 | https://conductscience.org/library/papers/24780091 | PubMed |
| 11 | 16757162 | Psychological interventions for adults with asthma: a systematic review. | Respir Med | 2007 | https://conductscience.org/library/papers/16757162 | PubMed |
| 12 | 19690661 | Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis. | Clinics (Sao Paulo) | 2009 | https://conductscience.org/library/papers/19690661 | PubMed |
| 13 | 23786930 | Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study. | Chin Med J (Engl) | 2013 | https://conductscience.org/library/papers/23786930 | PubMed |
| 14 | 8913417 | Effect of inhaled corticosteroids on the risk of cataract formation in patients with steroid-dependent asthma. | Ann Pharmacother | 1996 | https://conductscience.org/library/papers/8913417 | PubMed |
| 15 | 23427203 | 'The blue one takes a battering' why do young adults with asthma overuse bronchodilator inhalers? A qualitative study. | BMJ Open | 2013 | https://conductscience.org/library/papers/23427203 | PubMed |
| 16 | 22469599 | EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. | Rhinology | 2012 | https://conductscience.org/library/papers/22469599 | PubMed |
| 17 | 21749286 | Exercise challenge test: is a 15% fall in FEV(1) sufficient for diagnosis? | J Asthma | 2011 | https://conductscience.org/library/papers/21749286 | PubMed |
| 18 | 18079222 | Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. | Chest | 2007 | https://conductscience.org/library/papers/18079222 | PubMed |
| 19 | 21995339 | Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy. | Respirology | 2012 | https://conductscience.org/library/papers/21995339 | PubMed |
| 20 | 8542102 | Computed tomography of the lungs in asthma: influence of disease severity and etiology. | Am J Respir Crit Care Med | 1996 | https://conductscience.org/library/papers/8542102 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26528362
GET https://conductscience.org/api/papers/v1/26528362/authors?page=2